Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer

Molecular Medicine Reports

Volumn 12, Issue 1, 2015, Pages 615-622

  Wang, Lishui ^a   Liu, Yimin ^a   Du, Lutao ^a   Li, Juan ^a   Jiang, Xiumei ^a   Zheng, Guixi ^a   Qu, Ailin ^a   Wang, Haiyan ^a   Wang, Lili ^a   Zhang, Xin ^a   Liu, Hui ^a   Pan, Hongwei ^a   Yang, Yongmei ^a   Wang, Chuanxin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Bladder cancer; MicroRNAs; Reverse reference gene; Transcription quantitative polymerase chain reaction

Indexed keywords

COMPLEMENTARY DNA; MICRORNA; MICRORNA 141; MICRORNA 143; MICRORNA 16; MIRN16 MICRORNA, HUMAN; MIRN193 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD LEVEL; CANCER PATIENT; COMPUTER PROGRAM; CONTROLLED STUDY; DNA LIBRARY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ALGORITHM; GENETIC SCREENING; HUMAN; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; MUSCLE INVASIVE BLADDER CANCER; NON MUSCLE INVASIVE BLADDER CANCER; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; RNA STABILITY; UPREGULATION; VALIDATION STUDY; BIOSYNTHESIS; BLADDER TUMOR; BLOOD; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY;

AGED; BIOMARKERS, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; URINARY BLADDER NEOPLASMS;

EID: 84926613736     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3428     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
2. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
3. Kaufman DS, Shipley WU and Feldman AS: Bladder cancer. Lancet 374: 239-249, 2009.
4. Botteman MF, Pashos CL, Redaelli A, Laskin B and Hauser R: The health economics of bladder cancer: A comprehensive review of the published literature. Pharmacoeconomics 21: 1315-1330, 2003.
5. Malmström PU: Why has the survival of patients with bladder cancer not improved? BJU Int 101: 267-269, 2008.
6. Falebita OA, Sweeney P and Lee G: Urine cytology in the evaluation of urological malignancy revisited: is it still necessary. Urol Int 84: 45-49, 2010.
7. Mengual L, Lozano JJ, Ingelmo-Torres M, Gazquez C, Ribal MJ and Alcaraz A: Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer. Int J Cancer 133: 2631-2641, 2013.
8. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
9. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
10. Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233, 2009.
11. Heneghan HM, Miller N and Kerin MJ: MiRNAs as biomarkers and therapeutic targets in cancer. Curr Opin Pharmacol 10: 543-550, 2010.
12. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
13. Hunter MP, Ismail N, Zhang X, et al: Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 3: e3694, 2008.
14. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW and Lo YM: Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 54: 482-490, 2008.
15. Genovesi LA, Anderson D, Carter KW, Giles KM and Dallas PB: Identification of suitable endogenous control genes for microRNA expression profiling of childhood medulloblastoma and human neural stem cells. BMC Res Notes 5: 507, 2012.
16. Chang KH, Mestdagh P, Vandesompele J, Kerin MJ and Miller N: MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 10: 173, 2010.
17. Zheng G, Wang H, Zhang X, et al: Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients. PLoS ONE 8: e83025, 2013.
18. Cheng L, Montironi R, Davidson DD and Lopez-Beltran A: Staging and reporting of urothelial carcinoma of the urinary bladder. Mod Pathol 22 (Suppl 2): S70-S95, 2009.
19. Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE and Hoon DS: Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem 57: 84-91, 2011.
20. Zheng G, Wang H, Zhang X, Yang Y, Wang L, Du L, Li W, Li J, Qu A, Liu Y and Wang C: Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients. PLoS One 8: e83025, 2013.
21. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: research0034, 2002.
22. Adam L, Wszolek MF, Liu CG, Jing W, Diao L, Zien A, Zhang JD, Jackson D and Dinney CP: Plasma microRNA profiles for bladder cancer detection. Urol Oncol 31: 1701-1708, 2013.
23. Selth LA, Townley SL, Bert AG, Stricker PD, Sutherland PD, Horvath LG, Goodall GJ, Butler LM and Tilley WD: Circulating microRNAs predict biochemical recurrence in prostate cancer patients. Br J Cancer 109: 641-650, 2013.
24. Köberle V, Kronenberger B, Pleli T, et al: Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma. Eur J Cancer 49: 3442-3449, 2013.
25. Huang X, Liang M, Dittmar R and Wang L: Extracellular microRNAs in urologic malignancies: Chances and challenges. Int J Mol Sci 14: 14785-14799, 2013.
26. Liu R, Zhang C, Hu Z, et al: A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a finger-print for gastric cancer diagnosis. Eur J Cancer 47: 784-791, 2010.
27. Bediaga NG, Davies MP, Acha-Sagredo A, et al: A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material. Br J Cancer 109: 2404-2411, 2013.
28. Bargaje R, Hariharan M, Scaria V and Pillai B: Consensus miRNA expression profiles derived from interplatform normalization of microarray data. RNA 16: 16-25, 2010.
29. Chen X, Ba Y, Ma L, et al: Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006, 2008.
30. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, Tait JF and Tewari M: Blood cell origin of circulating microRNAs: A cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 5: 492-497, 2012.
31. Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Müller SC, Ellinger J. Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? World J Urol 32: 353-358, 2014.
32. Zhu HT, Dong QZ, Wang G, Zhou HJ, Ren N, Jia HL, Ye QH and Qin LX: Identification of suitable reference genes for qRT-PCR analysis of circulating microRNAs in hepatitis B virus-infected patients. Mol Biotechnol 50: 49-56, 2012.
33. Lardizábal MN, Nocito AL, Daniele SM, Ornella LA, Palatnik JF and Veggi LM: Reference genes for real-time PCR quantification of microRNAs and messenger RNAs in rat models of hepatotoxicity. PLoS ONE 7: e36323, 2012.
34. Song J, Bai Z, Han W, Zhang J, Meng H, Bi J, Ma X, Han S and Zhang Z: Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci 57: 897-904, 2012.
35. Kreth S, Heyn J, Grau S, Kretzschmar HA, Egensperger R and Kreth FW: Identification of valid endogenous control genes for determining gene expression in human glioma. Neuro-oncol 12: 570-579, 2010.
36. Hu Z, Dong J, Wang LE, et al: Serum microRNA profiling and breast cancer risk: The use of miR-484/191 as endogenous controls. Carcinogenesis 33: 828-834, 2012.
37. Peltier HJ and Latham GJ: Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852, 2008.
38. Wang Y, Tang N, Hui T, Wang S, Zeng X, Li H and Ma J. Identification of endogenous reference genes for RT-qPCR analysis of plasma microRNAs levels in rats with acetaminophen-induced hepatotoxicity. J Appl Toxicol 33: 1330-1336, 2013.
39. Andersen CL, Jensen JL and Ørntoft TF: Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64: 5245-5250, 2004.